Garden City, NY, April 28, 2023 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, is pleased to announce that Ted Karkus, CEO, has been named one of Inc Magazine’s 10 Most Innovative Healthcare Leaders to Watch in 2023. The annual listing represents…Read More
Related Posts
Ultragenyx Pharmaceutical Inc Ultragenyx Appoints Howard Horn as Chief Financial Officer and Executive Vice President…
NOVATO, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases,…
Sulfamic Acid Market to Generate USD 2376 billion at 46 CAGR by 2031 Globally Says…
Wilmington, Delaware, United States, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global sulfamic acid was estimated to have acquired US$ 154.3 billion in 2022. It…
Hybrid Operating Room Market to Exceed USD 18 billion by 2031 Garnering a 77 CAGR…
Wilmington, Delaware, United States, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global hybrid operating room market was estimated to have acquired US$ 876.9 million in…
